論文

査読有り
2009年11月

Anti-Angiogenic Cancer Therapy Updates

CURRENT MOLECULAR MEDICINE
  • A. M. Ali
  • ,
  • M. Toi
  • ,
  • T. Ueno

9
8
開始ページ
954
終了ページ
966
記述言語
英語
掲載種別
DOI
10.2174/156652409789712756
出版者・発行元
BENTHAM SCIENCE PUBL LTD

Anti-angiogenic therapy has fundamentally landmarked the clinical new era of anti-cancer therapy. It was demonstrated that the blockade of vascular endothelial growth factor results in regression of the disease and prolongation of survival. In contrast, it was clarified that the differential sensitivity of the therapeutic impact exists. Many thought-provoking questions have been raised in this field. Herein, we focus on the clinical data and attempt to summarize some clinical trials of anti-angiogenic treatment, highlighting the sparkling articles, the differential sensitivities to these agents beyond progression continuation, and how to individualize treatment according to validated biomarkers.

リンク情報
DOI
https://doi.org/10.2174/156652409789712756
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/19925408
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000271381400005&DestApp=WOS_CPL
ID情報
  • DOI : 10.2174/156652409789712756
  • ISSN : 1566-5240
  • PubMed ID : 19925408
  • Web of Science ID : WOS:000271381400005

エクスポート
BibTeX RIS